by Dan Roberts January, 2003 (Updated September, 2004) Scientists are researching a new method of retinal transplantation in the continuing effort to restore sight to the blind. Drs. Robert Aramant and Magdalene Seiler (Doheny Eye Institute, Los Angeles) have had preliminary success transplanting double layers of cells from the retinas of aborted fetuses. The two [Read More]
Category: Latest News
Second AMD Gene Discovered
A second gene, called fibulin 5, has been shown to be related to age-related macular degeneration (AMD). The discovery was announced in the July 22, 2004 issue of the New England Journal of Medicine by a team from the Research Center for Macular Degeneration and Allied Retinal Diseases at the University of Iowa. Earlier research [Read More]
FFB-Sponsored Study Leads to Discovery of New AMD Gene
(Press release from the Foundation Fighting Blindness) October 21, 2003 An exciting gene discovery by an FFB-funded researcher adds to the growing proof that macular degeneration can be hereditary. This is the first gene mutation found that is directly tied to age-related macular degeneration (AMD). The discovery of this gene mutation bolsters hope for a [Read More]
Study Demonstrates Essential Role of Zeaxanthin in Eye Health
Published by permission from RFB Communications Group, Inc. November 11, 2002 (Updated June 9, 2003) Schepens/Harvard study provides direct proof of dietary nutrient’s essential role in protecting the retina from the damaging effects of light. Skip to “Questions and Answers about Zeaxanthin”Research performed at Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School [Read More]
Microcurrent Stimulation Testimonial "Blown Out Of Proportion"
According to son, Sam Snead’s vision did not benefit from the controversial therapy by Dan Roberts Originally published, January 20, 2003 Microcurrent stimulation (MCS) therapy “didn’t work for my father,” said Sam Snead, Jr., son of the late champion golfer. Sam Snead, Sr., who passed away last year at the age of 89, underwent MCS [Read More]